Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study

被引：0
|
作者：
Felix Hasler
Ulrike Grimberg
Marco A. Benz
Theo Huber
Franz X. Vollenweider
机构：
[1] Psychiatric University Hospital Zürich,Heffter Research Center
来源：
Psychopharmacology | 2004年 / 172卷
关键词：
Psilocybin; Dose–effect study; Psycho(patho)logy; Neuroendocrinology; Cardiovascular effects; Altered states of consciousness;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：145 / 156
页数：11
相关论文
共 50 条
  • [1] Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study
    Hasler, F
    Grimberg, U
    Benz, MA
    Huber, T
    Vollenweider, FX
    PSYCHOPHARMACOLOGY, 2004, 172 (02) : 145 - 156
  • [2] A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans
    Kolida, S.
    Meyer, D.
    Gibson, G. R.
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2007, 61 (10) : 1189 - 1195
  • [3] A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans
    S Kolida
    D Meyer
    G R Gibson
    European Journal of Clinical Nutrition, 2007, 61 : 1189 - 1195
  • [4] Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects
    Becker, Anna M.
    Holze, Friederike
    Grandinetti, Tanja
    Klaiber, Aaron
    Toedtli, Vanja E.
    Kolaczynska, Karolina E.
    Duthaler, Urs
    Varghese, Nimmy
    Eckert, Anne
    Grunblatt, Edna
    Liechti, Matthias E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (04) : 886 - 895
  • [5] (Sub)acute effects of psilocybin on creative cognition: a double-blind, placebo-controlled experimental study
    Mason, N.
    Kuypers, K.
    Reckweg, J.
    Muller, F.
    Ramaekers, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 44 : S25 - S26
  • [6] Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
    Friederike Holze
    Laura Ley
    Felix Müller
    Anna M. Becker
    Isabelle Straumann
    Patrick Vizeli
    Sebastian Silva Kuehne
    Marc A. Roder
    Urs Duthaler
    Karolina E. Kolaczynska
    Nimmy Varghese
    Anne Eckert
    Matthias E. Liechti
    Neuropsychopharmacology, 2022, 47 : 1180 - 1187
  • [7] Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
    Holze, Friederike
    Ley, Laura
    Muller, Felix
    Becker, Anna M.
    Straumann, Isabelle
    Vizeli, Patrick
    Kuehne, Sebastian Silva
    Roder, Marc A.
    Duthaler, Urs
    Kolaczynska, Karolina E.
    Varghese, Nimmy
    Eckert, Anne
    Liechti, Matthias E.
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (06) : 1180 - 1187
  • [8] Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
    Cavanna, Federico
    Muller, Stephanie
    de la Fuente, Laura Alethia
    Zamberlan, Federico
    Palmucci, Matias
    Janeckova, Lucie
    Kuchar, Martin
    Pallavicini, Carla
    Tagliazucchi, Enzo
    TRANSLATIONAL PSYCHIATRY, 2022, 12 (01)
  • [9] Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
    Federico Cavanna
    Stephanie Muller
    Laura Alethia de la Fuente
    Federico Zamberlan
    Matías Palmucci
    Lucie Janeckova
    Martin Kuchar
    Carla Pallavicini
    Enzo Tagliazucchi
    Translational Psychiatry, 12
  • [10] Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects
    Aaron Klaiber
    Yasmin Schmid
    Anna M. Becker
    Isabelle Straumann
    Livio Erne
    Alen Jelusic
    Jan Thomann
    Dino Luethi
    Matthias E. Liechti
    Translational Psychiatry, 14 (1)
12345